title: Compliance with hormone replacement therapy in postmenopausal women. A comparative study.
abstract: OBJECTIVE
  To assess compliance with hormone replacement therapy in postmenopausal women.
  
  
  METHODS
  Two groups were compared prospectively: 100 women who sought treatment for menopausal symptoms, and 82 women who had undergone a total abdominal hysterectomy with bilateral salpingo-oophorectomy and were using estrogen replacement therapy.
  
  
  RESULTS
  Compliance rates after 6 months were 81.0% and 84.1% in the two groups, respectively, and after 12 months, 73.0% and 80.5%.
  
  
  CONCLUSIONS
  The high rates are attributed to our investment in patient education of the benefits of treatment and repeated and close follow-up.
authors.affiliation: Department of Obstetrics and Gynecology, Rabin Medical Center, Petah Tiqwa, Israel.
authors.forename: G A
authors.initials: GA
authors.lastname: Goldman
authors.forename: B
authors.initials: B
authors.lastname: Kaplan
authors.forename: D M
authors.initials: DM
authors.lastname: Leiserowitz
authors.forename: Y
authors.initials: Y
authors.lastname: Pardo
authors.forename: R
authors.initials: R
authors.lastname: Amster
authors.forename: B
authors.initials: B
authors.lastname: Fisch
mesh_terms: D000328:Adult; D015914:Estrogen Replacement Therapy; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D008875:Middle Aged; D010349:Patient Compliance; D045167:Progesterone Congeners / Q000627:therapeutic use; D011446:Prospective Studies
chemical_list: D004966:Estrogens, Conjugated (USP); D045167:Progesterone Congeners; D017258:Medroxyprogesterone Acetate